无码欧美成人av天堂456软件,大胆日本熟妇XXXX,9277在线观看免费播放,4p三个男人让我爽了一夜,亲爱的老师5韩国中字完整版,结婚七年电影,爱缠绵在线韩国电影,亚洲永久熟女少妇25b,韩国电影伦理片在线观看,欧美一区二区三区四区

抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：

1. 細(xì)胞核因子/k基因結(jié)合核因子抗體品牌 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；

2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件；

3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；

4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；

5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；

6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合；

7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；

8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。

產(chǎn)品訂購(gòu)信息：
英文名稱  Anti-NFKB p65 

中文名稱   細(xì)胞核因子/k基因結(jié)合核因子抗體品牌 

別    名  NFKBp65; NF-κBp65; NF-kBp65; Avian reticuloendotheliosis viral (v rel) oncogene homolog A; MGC131774; NFKB 3; NFKB3; Nuclear Factor NF Kappa B p65 Subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B Cells; p65; p65 NF kappaB; p65 NFkB; RELA; Transcription Factor p65; v rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B cells 3 (p65)); V Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A; v rel reticuloendotheliosis viral oncogene homolog A (avian); v-rel reticuloendotheliosis viral oncogene homolog A; p65NFKB; TF65_HUMAN.

濃    度   1mg/1ml

規(guī) 格  0.1ml/100μg 0.2ml/200μg

抗體來(lái)源   Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit 

產(chǎn)品類型   一抗  

研究領(lǐng)域    細(xì)胞生物 免疫學(xué) 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子

蛋白分子量  predicted molecular weight: 61kDa

性    狀   Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from human NFKBp65 N-terminus 

亞    型   IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

細(xì)胞核因子/k基因結(jié)合核因子抗體品牌 產(chǎn)品應(yīng)用    WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011].

Function : NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappa-B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-kappa-B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1.Subunit : Component of the NF-kappa-B p65-p50 complex. Component of the NF-kappa-B p65-c-Rel complex. Homodimer; component of the NF-kappa-B p65-p65 complex. Component of the NF-kappa-B p65-p52 complex. May interact with ETHE1. Binds AES and TLE1. Interacts with TP53BP2. Binds to and is phosphorylated by the activated form of either RPS6KA4 or RPS6KA5. Interacts with ING4 and this interaction may be indirect. Interacts with CARM1, USP48 and UNC5CL. Interacts with IRAK1BP1 (By similarity). Interacts with NFKBID (By similarity). Interacts with NFKBIA. Interacts with GSK3B. Interacts with NFKBIB (By similarity). Interacts with NFKBIE. Interacts with NFKBIZ. Interacts with EHMT1 (via ANK repeats) (By similarity). Part of a 70-90 kDa complex at least consisting of CHUK, IKBKB, NFKBIA, RELA, IKBKAP and MAP3K14. Interacts with HDAC3; HDAC3 mediates the deacetylation of RELA. Interacts with HDAC1; the interaction requires non-phosphorylated RELA. Interacts with CBP; the interaction requires phosphorylated RELA. Interacts (phosphorylated at 'Thr-254') with PIN1; the interaction inhibits p65 binding to NFKBIA. Interacts with SOCS1. Interacts with UXT. Interacts with MTDH and PHF11. Interacts with ARRB2. Interacts with human respiratory syncytial virus (HRSV) protein M2-1. Interacts with NFKBIA (when phosphorylated), the interaction is direct; phosphorylated NFKBIA is part of a SCF(BTRC)-like complex lacking CUL1. Interacts with RNF25. Interacts (via C-terminus) with DDX1. Interacts with UFL1 and COMMD1. Interacts with BRMS1; this promotes deacetylation of 'Lys-310'. Interacts with NOTCH2 (By similarity). Directly interacts with MEN1; this interaction represses NFKB-mediated transactivation. Interacts with AKIP1, which promotes the phosphorylation and nuclear retention of RELA. Interacts (via the RHD) with GFI1; the interaction, after bacterial lipopolysaccharide (LPS) stimulation, inhibits the transcriptional activity by interfering with the DNA-binding activity to target gene promoter DNA.Subcellular Location : Nucleus. Cytoplasm. Note=Colocalized with DDX1 in the nucleus upon TNF-alpha induction. Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B). Colocalizes with GFI1 in the nucleus after LPS stimulation.Post-translational modifications : Ubiquitinated, leading to its proteasomal degradation. Degradation is required for termination of NF-kappa-B response.Monomethylated at Lys-310 by SETD6. Monomethylation at Lys-310 is recognized by the ANK repeats of EHMT1 and promotes the formation of repressed chromatin at target genes, leading to down-regulation of NF-kappa-B transcription factor activity. Phosphorylation at Ser-311 disrupts the interaction with EHMT1 without preventing monomethylation at Lys-310 and relieves the repression of target genes.Phosphorylation at Ser-311 disrupts the interaction with EHMT1 and promotes transcription factor activity. Phosphorylation on Ser-536 stimulates acetylation on Lys-310 and interaction with CBP; the phosphorylated and acetylated forms show enhanced transcriptional activity. Phosphorylation at Ser-276 by RPS6KA4 and RPS6KA5 promotes its transactivation and transcriptional activities.Reversibly acetylated; the acetylation seems to be mediated by CBP, the deacetylation by HDAC3 and SIRT2. Acetylation at Lys-122 enhances DNA binding and impairs association with NFKBIA. Acetylation at Lys-310 is required for full transcriptional activity in the absence of effects on DNA binding and NFKBIA association. Acetylation can also lower DNA-binding and results in nuclear export. Interaction with BRMS1 promotes deacetylation of Lys-310. Lys-310 is deacetylated by SIRT2.S-nitrosylation of Cys-38 inactivates the enzyme activity.Sulfhydration at Cys-38 mediates the anti-apoptotic activity by promoting the interaction with RPS3 and activating the transcription factor activity.Sumoylation by PIAS3 negatively regulates DNA-bound activated NF-kappa-B.Similarity : Contains 1 RHD (Rel-like) domain.Database links :Entrez Gene: 5970 HumanEntrez Gene: 19697 MouseEntrez Gene: 309165 RatOmim: 164014 HumanSwissProt: Q04206 HumanSwissProt: Q04207 MouseUnigene: 502875 HumanUnigene: 249966 MouseUnigene: 19480 Rat轉(zhuǎn)錄調(diào)節(jié)因子（Transcriptin Regulators）NF-κBp65是一種重要的轉(zhuǎn)錄因子，NF-kBp65可激活參與、細(xì)胞增殖、細(xì)胞凋亡等基因的調(diào)節(jié)，影響著細(xì)胞的凋亡，同時(shí)影響著細(xì)胞對(duì)細(xì)胞毒性藥物及離子輻射的敏感性。ras基因誘導(dǎo)的致癌突變作用需NFkB的活化，提示NFkB在致癌發(fā)生方面可能起一定作用；另有文獻(xiàn)報(bào)道，在、非小細(xì)胞性、、T或B淋巴細(xì)胞及誘變導(dǎo)致的等人類中，NFkB活化或表達(dá)。經(jīng)研究認(rèn)為：NFKBp65蛋白在靜息狀態(tài)下以結(jié)合態(tài)的方式存在于胞漿中，當(dāng)NFKBp65蛋白被激活后解離進(jìn)入細(xì)胞核。(NF-κB與其抑制蛋白IκB家族成員結(jié)合，以無(wú)活性的復(fù)合物形式存在于胞漿中，當(dāng)細(xì)胞受到各種刺激后，NF- κB與IκB 解離，從而進(jìn)入細(xì)胞核，與相應(yīng)的靶序列結(jié)合，調(diào)節(jié)基因的表達(dá))

抗體的鑒定：

1）細(xì)胞核因子/k基因結(jié)合核因子抗體品牌 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。

2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。 

如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。

3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。

ASM(Human acid sphingomyelinase) ELISA Kit 人酸性神經(jīng)鞘磷脂酶Multi-class antibodies規(guī)格： 48T

Anti-Nociceptin receptor 孤菲肽受體/痛敏肽受體抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh IL-1 Beta/IL-1B 白介素1β抗體 IL-1β 規(guī)格 0.1ml

IL-1sR I ELISA Kit 大鼠白介素1可溶性受體Ⅰ 96T

Pokemon/ZBTB7 英文名稱： 蒙蛋白抗體 0.1ml

Cytochrome C 英文名稱： 細(xì)胞色素C抗體 0.1ml

Anti-Nociceptin receptor 孤菲肽受體/痛敏肽受體抗體Multi-class antibodies規(guī)格： 0.2ml

FE(Mouse ferritin) ELISA KIT 小鼠鐵蛋白Multi-class antibodies規(guī)格： 48T

Anti-CD31/FITC 熒光素標(biāo)記血小板內(nèi)皮細(xì)胞黏附分子-1抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh DVL2 蓬亂蛋白2抗體 規(guī)格 0.2ml

Rotavirus IgM 輪狀病毒 IgM(間接法二步法)

MMP19 英文名稱： 基質(zhì)金屬蛋白酶18/19 0.2ml

ADAMTS7(NT) 英文名稱： 整合素樣金屬蛋白酶與凝血酶1型-7抗體 (N端抗體) 0.1ml

Anti-CD31/FITC 熒光素標(biāo)記血小板內(nèi)皮細(xì)胞黏附分子-1抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-GPC3/FITC 熒光素標(biāo)記磷脂?；嫉鞍拙厶?3抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-P38 MAPK/FITC 熒光素標(biāo)記原活化蛋白激酶p38抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Beta-arrestin 1 β-抑制蛋白1抗體 規(guī)格 0.2ml

CR (Calretinin) 鈣結(jié)合蛋白(抗原) 0.5mg

Histone H1t 英文名稱： 組蛋白H1抗體 0.1ml

Rhesus antibody Rh RASA3 Ras-GTP酶激活蛋白3抗體 規(guī)格 0.2ml

Anti-P38 MAPK/FITC 熒光素標(biāo)記原活化蛋白激酶p38抗體IgGMulti-class antibodies規(guī)格： 0.2ml

纖維二糖-多粘菌素E(CC)瓊脂250g用于弧菌分離培養(yǎng)基

GAMBroth,Modified

皰肉牛肉粒 Dried Meat Particle 100 加入皰肉基礎(chǔ)中，配成皰肉培養(yǎng)基

膽鹽硫乳瓊脂培養(yǎng)基250g/瓶用于腸道致病菌的選擇性分離incubationmedia膽鹽硫乳瓊脂培養(yǎng)基250g/瓶用于腸道致病菌的選擇性分離

MRS瓊脂平板(9cm) 10個(gè)/包 用于食品中乳酸菌總數(shù)測(cè)定

ChinaBlueAgar

酪蛋白胨卵磷脂聚山梨醇脂肉湯 incubation media 酪蛋白胨卵磷脂聚山梨醇脂肉湯

胰蛋白胨大豆瓊脂培養(yǎng)基 250g 用于普通的或營(yíng)養(yǎng)要求較高的細(xì)菌的培養(yǎng)，還用于醫(yī)藥工業(yè)潔凈室無(wú)菌程度的監(jiān)測(cè)及消毒劑消毒效果的...

SD大鼠骨髓間質(zhì)干細(xì)胞成骨誘導(dǎo)分化培養(yǎng)基SDratbonemarrowmesenchymalstemcellsandosteogenicdifferentiationmedium

牛津瓊脂(OXA)基礎(chǔ) 250g 用于單增李氏菌的選擇性分離(SN標(biāo)準(zhǔn))

細(xì)胞核因子/k基因結(jié)合核因子抗體品牌 玫瑰紅瓊脂瓶裝顆粒培養(yǎng)基  規(guī)格：  250g  用途：  供藥品和生物制品中霉菌和酵母菌的計(jì)數(shù)、分離和培養(yǎng)用

煌綠乳糖膽鹽肉湯BGLB瓶裝顆粒培養(yǎng)基  規(guī)格：  250g  用途：  用于多管發(fā)酵法測(cè)定大腸菌群的確證試驗(yàn)

緩沖蛋白胨水瓶裝顆粒培養(yǎng)基(BPW)  規(guī)格：  250g  用途：  用于食品中沙門氏菌的前增菌培養(yǎng)

膽鹽乳糖瓶裝顆粒培養(yǎng)基  規(guī)格：  250g  用途：  用于藥品中大腸桿菌和綠膿桿菌的增菌培養(yǎng)